Zhenbin Jiang

Peking University

Papers

1

Total Citations

3

H-Index

1

About

Dr. Zhenbin Jiang is a leading urologic oncologist whose research focuses on the surgical management of advanced renal cell carcinoma (RCC), particularly cases involving venous tumor thrombus (VTT). His major contributions center on elucidating the critical interplay between aggressive surgical intervention and postoperative renal function. Through his systematic review on risk factors for renal insufficiency following radical nephrectomy and thrombectomy, Dr. Jiang provides essential evidence-based guidance for optimizing patient outcomes in this high-risk population. This work, already garnering citations shortly after its 2025 publication, highlights his commitment to refining surgical strategies that balance oncologic efficacy with renal preservation. By systematically analyzing survival implications and complication profiles, his research directly informs clinical decision-making for one of urology's most challenging procedures. Dr. Jiang's scholarship is vital for surgeons navigating the complex trade-offs inherent in treating RCC with tumor thrombus, establishing him as an emerging authority in this specialized field.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Risk factors for renal insufficiency and survival implications after radical nephrectomy and thrombectomy in renal cell carcinoma with tumor thrombus: a systematic review
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Peking University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago